These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 10951238)

  • 1. Relationship between cell-associated matrix metalloproteinase 9 and psoriatic keratinocyte growth.
    Buisson-Legendre N; Emonard H; Bernard P; Hornebeck W
    J Invest Dermatol; 2000 Aug; 115(2):213-8. PubMed ID: 10951238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of the 92-kDa gelatinase (matrix metalloproteinase-9) in the ceramide-mediated inhibition of human keratinocyte growth.
    Buisson-Legendre N; Bernard P; Bobichon H; Emonard H; Schneider C; Maquart FX; Haye B; Hornebeck W
    Biochem Biophys Res Commun; 1999 Jul; 260(3):634-40. PubMed ID: 10403818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinase 2 (gelatinase A) is related to migration of keratinocytes.
    Mäkelä M; Larjava H; Pirilä E; Maisi P; Salo T; Sorsa T; Uitto VJ
    Exp Cell Res; 1999 Aug; 251(1):67-78. PubMed ID: 10438572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rosiglitazone inhibits proliferation, motility, and matrix metalloproteinase production in keratinocytes.
    Bhagavathula N; Nerusu KC; Lal A; Ellis CN; Chittiboyina A; Avery MA; Ho CI; Benson SC; Pershadsingh HA; Kurtz TW; Varani J
    J Invest Dermatol; 2004 Jan; 122(1):130-9. PubMed ID: 14962101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arginase 1 overexpression in psoriasis: limitation of inducible nitric oxide synthase activity as a molecular mechanism for keratinocyte hyperproliferation.
    Bruch-Gerharz D; Schnorr O; Suschek C; Beck KF; Pfeilschifter J; Ruzicka T; Kolb-Bachofen V
    Am J Pathol; 2003 Jan; 162(1):203-11. PubMed ID: 12507903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normalized proliferation of normal and psoriatic keratinocytes by suppression of sAPPalpha-release.
    Siemes C; Quast T; Klein E; Bieber T; Hooper NM; Herzog V
    J Invest Dermatol; 2004 Sep; 123(3):556-63. PubMed ID: 15304096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of genes for metalloproteinases (MMP-1, MMP-2, MMP-9, and MMP-12) associated with psoriasis].
    Starodubtseva NL; Sobolev VV; Soboleva AG; Nikolaev AA; Bruskin SA
    Genetika; 2011 Sep; 47(9):1254-61. PubMed ID: 22117411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperglycaemic conditions decrease cultured keratinocyte mobility: implications for impaired wound healing in patients with diabetes.
    Lan CC; Liu IH; Fang AH; Wen CH; Wu CS
    Br J Dermatol; 2008 Nov; 159(5):1103-15. PubMed ID: 18717678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant production of interleukin-8 and thrombospondin-1 by psoriatic keratinocytes mediates angiogenesis.
    Nickoloff BJ; Mitra RS; Varani J; Dixit VM; Polverini PJ
    Am J Pathol; 1994 Apr; 144(4):820-8. PubMed ID: 7512793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MMP-9 from TNF alpha-stimulated keratinocytes binds to cell membranes and type I collagen: a cause for extended matrix degradation in inflammation?
    Mäkelä M; Salo T; Larjava H
    Biochem Biophys Res Commun; 1998 Dec; 253(2):325-35. PubMed ID: 9878537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MMP-2, -9 and TIMP-1, -2 assays in keratinocyte cultures.
    Kobayashi T
    Methods Mol Biol; 2014; 1195():145-55. PubMed ID: 24281866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinase-19 is expressed by keratinocytes in psoriasis.
    Suomela S; Kariniemi AL; Impola U; Karvonen SL; Snellman E; Uurasmaa T; Peltonen J; Saarialho-Kere U
    Acta Derm Venereol; 2003; 83(2):108-14. PubMed ID: 12735638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast-keratinocyte interactions in psoriasis: failure of psoriatic fibroblasts to stimulate keratinocyte proliferation in vitro.
    Priestley GC; Lord R
    Br J Dermatol; 1990 Oct; 123(4):467-72. PubMed ID: 2095178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonism of epidermal growth factor receptor tyrosine kinase ameliorates the psoriatic phenotype in organ-cultured skin.
    Varani J; Lateef H; Fay K; Elder JT
    Skin Pharmacol Physiol; 2005; 18(3):123-31. PubMed ID: 15897684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics and regulation of human keratinocyte stem cell growth in short-term primary ex vivo culture. Cooperative growth factors from psoriatic lesional T lymphocytes stimulate proliferation among psoriatic uninvolved, but not normal, stem keratinocytes.
    Bata-Csorgo Z; Hammerberg C; Voorhees JJ; Cooper KD
    J Clin Invest; 1995 Jan; 95(1):317-27. PubMed ID: 7529261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of retinoic acid on keratinocyte proliferation and differentiation in a psoriatic skin model.
    Jean J; Soucy J; Pouliot R
    Tissue Eng Part A; 2011 Jul; 17(13-14):1859-68. PubMed ID: 21417679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth-inhibitory effects of 1,25-dihydroxyvitamin D3 on normal and psoriatic keratinocytes.
    Hashimoto K; Matsumoto K; Higashiyama M; Nishida Y; Yoshikawa K
    Br J Dermatol; 1990 Jul; 123(1):93-8. PubMed ID: 2390499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of insulin-like growth factor-I/somatomedin C on thymidine incorporation in cultured psoriatic keratinocytes after growth arrest in growth factor-free medium.
    Ristow HJ
    Growth Regul; 1993 Jun; 3(2):129-37. PubMed ID: 8339046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of cell death and proliferation in psoriatic epidermis.
    Kawashima K; Doi H; Ito Y; Shibata MA; Yoshinaka R; Otsuki Y
    J Dermatol Sci; 2004 Sep; 35(3):207-14. PubMed ID: 15381242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinase inhibitor BB-3103 unlike the serine proteinase inhibitor aprotinin abrogates epidermal healing of human skin wounds ex vivo.
    Mirastschijski U; Impola U; Karsdal MA; Saarialho-Kere U; Agren MS
    J Invest Dermatol; 2002 Jan; 118(1):55-64. PubMed ID: 11851876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.